Global Parkinson Disease Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026
The Parkinson Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Parkinson Disease Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Parkinson Disease Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Parkinson Disease Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market segment by Application, can be divided into
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Market segment by players, this report covers
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Parkinson Disease Drug
1.2 Classification of Parkinson Disease Drug by Type
1.2.1 Overview: Global Parkinson Disease Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Parkinson Disease Drug Revenue Market Share by Type in 2020
1.2.3 Sinemet-CR
1.2.4 Trastal
1.2.5 Madopar
1.2.6 COMT Inhibitor
1.2.7 Other
1.3 Global Parkinson Disease Drug Market by Application
1.3.1 Overview: Global Parkinson Disease Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson Disease Drug Market Size & Forecast
1.5 Global Parkinson Disease Drug Market Size and Forecast by Region
1.5.1 Global Parkinson Disease Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Parkinson Disease Drug Market Size by Region, (2016-2021)
1.5.3 North America Parkinson Disease Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Parkinson Disease Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Parkinson Disease Drug Market Size and Prospect (2016-2026)
1.5.6 South America Parkinson Disease Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Parkinson Disease Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinson Disease Drug Market Drivers
1.6.2 Parkinson Disease Drug Market Restraints
1.6.3 Parkinson Disease Drug Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Parkinson Disease Drug Product and Solutions
2.1.4 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Akorn
2.2.1 Akorn Details
2.2.2 Akorn Major Business
2.2.3 Akorn Parkinson Disease Drug Product and Solutions
2.2.4 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Akorn Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Parkinson Disease Drug Product and Solutions
2.3.4 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GSK Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Parkinson Disease Drug Product and Solutions
2.4.4 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
2.5.4 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
2.6.4 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
2.7 Abbvie
2.7.1 Abbvie Details
2.7.2 Abbvie Major Business
2.7.3 Abbvie Parkinson Disease Drug Product and Solutions
2.7.4 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Abbvie Recent Developments and Future Plans
2.8 Kyowa Hakko Kirin Pharma
2.8.1 Kyowa Hakko Kirin Pharma Details
2.8.2 Kyowa Hakko Kirin Pharma Major Business
2.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
2.8.4 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business
2.9.3 Astellas Pharma Parkinson Disease Drug Product and Solutions
2.9.4 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Astellas Pharma Recent Developments and Future Plans
2.10 Desitin Arzneimittel
2.10.1 Desitin Arzneimittel Details
2.10.2 Desitin Arzneimittel Major Business
2.10.3 Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
2.10.4 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Desitin Arzneimittel Recent Developments and Future Plans
2.11 Endo Pharmaceuticals
2.11.1 Endo Pharmaceuticals Details
2.11.2 Endo Pharmaceuticals Major Business
2.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
2.11.4 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.12 F.Hoffmann-La Roche
2.12.1 F.Hoffmann-La Roche Details
2.12.2 F.Hoffmann-La Roche Major Business
2.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
2.12.4 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 F.Hoffmann-La Roche Recent Developments and Future Plans
2.13 H.Lundbeck
2.13.1 H.Lundbeck Details
2.13.2 H.Lundbeck Major Business
2.13.3 H.Lundbeck Parkinson Disease Drug Product and Solutions
2.13.4 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 H.Lundbeck Recent Developments and Future Plans
2.14 Valeant
2.14.1 Valeant Details
2.14.2 Valeant Major Business
2.14.3 Valeant Parkinson Disease Drug Product and Solutions
2.14.4 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Valeant Recent Developments and Future Plans
2.15 Apokyn
2.15.1 Apokyn Details
2.15.2 Apokyn Major Business
2.15.3 Apokyn Parkinson Disease Drug Product and Solutions
2.15.4 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Apokyn Recent Developments and Future Plans
2.16 Orion
2.16.1 Orion Details
2.16.2 Orion Major Business
2.16.3 Orion Parkinson Disease Drug Product and Solutions
2.16.4 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Orion Recent Developments and Future Plans
2.17 Stada Arzneimittel
2.17.1 Stada Arzneimittel Details
2.17.2 Stada Arzneimittel Major Business
2.17.3 Stada Arzneimittel Parkinson Disease Drug Product and Solutions
2.17.4 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Stada Arzneimittel Recent Developments and Future Plans
2.18 US WorldMeds
2.18.1 US WorldMeds Details
2.18.2 US WorldMeds Major Business
2.18.3 US WorldMeds Parkinson Disease Drug Product and Solutions
2.18.4 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 US WorldMeds Recent Developments and Future Plans
2.19 Bausch Health
2.19.1 Bausch Health Details
2.19.2 Bausch Health Major Business
2.19.3 Bausch Health Parkinson Disease Drug Product and Solutions
2.19.4 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Bausch Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Parkinson Disease Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Parkinson Disease Drug Players Market Share
3.2.2 Top 10 Parkinson Disease Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Parkinson Disease Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Parkinson Disease Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Parkinson Disease Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Parkinson Disease Drug Revenue Market Share by Application (2016-2021)
5.2 Parkinson Disease Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Parkinson Disease Drug Revenue by Type (2016-2026)
6.2 North America Parkinson Disease Drug Revenue by Application (2016-2026)
6.3 North America Parkinson Disease Drug Market Size by Country
6.3.1 North America Parkinson Disease Drug Revenue by Country (2016-2026)
6.3.2 United States Parkinson Disease Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Parkinson Disease Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Parkinson Disease Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Parkinson Disease Drug Revenue by Type (2016-2026)
7.2 Europe Parkinson Disease Drug Revenue by Application (2016-2026)
7.3 Europe Parkinson Disease Drug Market Size by Country
7.3.1 Europe Parkinson Disease Drug Revenue by Country (2016-2026)
7.3.2 Germany Parkinson Disease Drug Market Size and Forecast (2016-2026)
7.3.3 France Parkinson Disease Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Parkinson Disease Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Parkinson Disease Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Parkinson Disease Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Parkinson Disease Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Parkinson Disease Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Parkinson Disease Drug Market Size by Region
8.3.1 Asia-Pacific Parkinson Disease Drug Revenue by Region (2016-2026)
8.3.2 China Parkinson Disease Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Parkinson Disease Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Parkinson Disease Drug Market Size and Forecast (2016-2026)
8.3.5 India Parkinson Disease Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Parkinson Disease Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Parkinson Disease Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Parkinson Disease Drug Revenue by Type (2016-2026)
9.2 South America Parkinson Disease Drug Revenue by Application (2016-2026)
9.3 South America Parkinson Disease Drug Market Size by Country
9.3.1 South America Parkinson Disease Drug Revenue by Country (2016-2026)
9.3.2 Brazil Parkinson Disease Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Parkinson Disease Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Parkinson Disease Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Parkinson Disease Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Parkinson Disease Drug Market Size by Country
10.3.1 Middle East & Africa Parkinson Disease Drug Revenue by Country (2016-2026)
10.3.2 Turkey Parkinson Disease Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Parkinson Disease Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Parkinson Disease Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Parkinson Disease Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Parkinson Disease Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Parkinson Disease Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Parkinson Disease Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Parkinson Disease Drug Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Parkinson Disease Drug Product and Solutions
Table 9. Merck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Akorn Corporate Information, Head Office, and Major Competitors
Table 11. Akorn Major Business
Table 12. Akorn Parkinson Disease Drug Product and Solutions
Table 13. Akorn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GSK Corporate Information, Head Office, and Major Competitors
Table 15. GSK Major Business
Table 16. GSK Parkinson Disease Drug Product and Solutions
Table 17. GSK Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Parkinson Disease Drug Product and Solutions
Table 21. Novartis Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 23. Boehringer Ingelheim Major Business
Table 24. Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
Table 25. Boehringer Ingelheim Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 27. Teva Pharmaceutical Major Business
Table 28. Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
Table 29. Teva Pharmaceutical Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Abbvie Corporate Information, Head Office, and Major Competitors
Table 31. Abbvie Major Business
Table 32. Abbvie Parkinson Disease Drug Product and Solutions
Table 33. Abbvie Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kyowa Hakko Kirin Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Kyowa Hakko Kirin Pharma Major Business
Table 36. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
Table 37. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Astellas Pharma Major Business
Table 40. Astellas Pharma Parkinson Disease Drug Product and Solutions
Table 41. Astellas Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Desitin Arzneimittel Corporate Information, Head Office, and Major Competitors
Table 43. Desitin Arzneimittel Major Business
Table 44. Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
Table 45. Desitin Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Endo Pharmaceuticals Major Business
Table 48. Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
Table 49. Endo Pharmaceuticals Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. F.Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 51. F.Hoffmann-La Roche Major Business
Table 52. F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
Table 53. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. H.Lundbeck Corporate Information, Head Office, and Major Competitors
Table 55. H.Lundbeck Major Business
Table 56. H.Lundbeck Parkinson Disease Drug Product and Solutions
Table 57. H.Lundbeck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Valeant Corporate Information, Head Office, and Major Competitors
Table 59. Valeant Major Business
Table 60. Valeant Parkinson Disease Drug Product and Solutions
Table 61. Valeant Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Apokyn Corporate Information, Head Office, and Major Competitors
Table 63. Apokyn Major Business
Table 64. Apokyn Parkinson Disease Drug Product and Solutions
Table 65. Apokyn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Orion Corporate Information, Head Office, and Major Competitors
Table 67. Orion Major Business
Table 68. Orion Parkinson Disease Drug Product and Solutions
Table 69. Orion Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Stada Arzneimittel Corporate Information, Head Office, and Major Competitors
Table 71. Stada Arzneimittel Major Business
Table 72. Stada Arzneimittel Parkinson Disease Drug Product and Solutions
Table 73. Stada Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. US WorldMeds Corporate Information, Head Office, and Major Competitors
Table 75. US WorldMeds Major Business
Table 76. US WorldMeds Parkinson Disease Drug Product and Solutions
Table 77. US WorldMeds Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 79. Bausch Health Major Business
Table 80. Bausch Health Parkinson Disease Drug Product and Solutions
Table 81. Bausch Health Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Global Parkinson Disease Drug Revenue (USD Million) by Players (2019-2021)
Table 83. Global Parkinson Disease Drug Revenue Share by Players (2019-2021)
Table 84. Breakdown of Parkinson Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Parkinson Disease Drug Players Head Office, Products and Services Provided
Table 86. Parkinson Disease Drug Mergers & Acquisitions in the Past Five Years
Table 87. Parkinson Disease Drug New Entrants and Expansion Plans
Table 88. Global Parkinson Disease Drug Revenue (USD Million) by Type (2016-2021)
Table 89. Global Parkinson Disease Drug Revenue Share by Type (2016-2021)
Table 90. Global Parkinson Disease Drug Revenue Forecast by Type (2021-2026)
Table 91. Global Parkinson Disease Drug Revenue by Application (2016-2021)
Table 92. Global Parkinson Disease Drug Revenue Forecast by Application (2021-2026)
Table 93. North America Parkinson Disease Drug Revenue by Type (2016-2021) & (USD Million)
Table 94. North America Parkinson Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 95. North America Parkinson Disease Drug Revenue by Application (2016-2021) & (USD Million)
Table 96. North America Parkinson Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 97. North America Parkinson Disease Drug Revenue by Country (2016-2021) & (USD Million)
Table 98. North America Parkinson Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 99. Europe Parkinson Disease Drug Revenue by Type (2016-2021) & (USD Million)
Table 100. Europe Parkinson Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 101. Europe Parkinson Disease Drug Revenue by Application (2016-2021) & (USD Million)
Table 102. Europe Parkinson Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 103. Europe Parkinson Disease Drug Revenue by Country (2016-2021) & (USD Million)
Table 104. Europe Parkinson Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 105. Asia-Pacific Parkinson Disease Drug Revenue by Type (2016-2021) & (USD Million)
Table 106. Asia-Pacific Parkinson Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 107. Asia-Pacific Parkinson Disease Drug Revenue by Application (2016-2021) & (USD Million)
Table 108. Asia-Pacific Parkinson Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 109. Asia-Pacific Parkinson Disease Drug Revenue by Region (2016-2021) & (USD Million)
Table 110. Asia-Pacific Parkinson Disease Drug Revenue by Region (2021-2026) & (USD Million)
Table 111. South America Parkinson Disease Drug Revenue by Type (2016-2021) & (USD Million)
Table 112. South America Parkinson Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 113. South America Parkinson Disease Drug Revenue by Application (2016-2021) & (USD Million)
Table 114. South America Parkinson Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 115. South America Parkinson Disease Drug Revenue by Country (2016-2021) & (USD Million)
Table 116. South America Parkinson Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Parkinson Disease Drug Revenue by Type (2016-2021) & (USD Million)
Table 118. Middle East & Africa Parkinson Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 119. Middle East & Africa Parkinson Disease Drug Revenue by Application (2016-2021) & (USD Million)
Table 120. Middle East & Africa Parkinson Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 121. Middle East & Africa Parkinson Disease Drug Revenue by Country (2016-2021) & (USD Million)
Table 122. Middle East & Africa Parkinson Disease Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Revenue Market Share by Type in 2020
Figure 3. Sinemet-CR
Figure 4. Trastal
Figure 5. Madopar
Figure 6. COMT Inhibitor
Figure 7. Other
Figure 8. Parkinson Disease Drug Revenue Market Share by Application in 2020
Figure 9. Under 40 Years Old Picture
Figure 10. 40-65 Years Old Picture
Figure 11. Above 65 Years Old Picture
Figure 12. Global Parkinson Disease Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Parkinson Disease Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Parkinson Disease Drug Revenue Market Share by Region (2016-2026)
Figure 15. Global Parkinson Disease Drug Revenue Market Share by Region in 2020
Figure 16. North America Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Parkinson Disease Drug Market Drivers
Figure 22. Parkinson Disease Drug Market Restraints
Figure 23. Parkinson Disease Drug Market Trends
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Akorn Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Boehringer Ingelheim Recent Developments and Future Plans
Figure 29. Teva Pharmaceutical Recent Developments and Future Plans
Figure 30. Abbvie Recent Developments and Future Plans
Figure 31. Kyowa Hakko Kirin Pharma Recent Developments and Future Plans
Figure 32. Astellas Pharma Recent Developments and Future Plans
Figure 33. Desitin Arzneimittel Recent Developments and Future Plans
Figure 34. Endo Pharmaceuticals Recent Developments and Future Plans
Figure 35. F.Hoffmann-La Roche Recent Developments and Future Plans
Figure 36. H.Lundbeck Recent Developments and Future Plans
Figure 37. Valeant Recent Developments and Future Plans
Figure 38. Apokyn Recent Developments and Future Plans
Figure 39. Orion Recent Developments and Future Plans
Figure 40. Stada Arzneimittel Recent Developments and Future Plans
Figure 41. US WorldMeds Recent Developments and Future Plans
Figure 42. Bausch Health Recent Developments and Future Plans
Figure 43. Global Parkinson Disease Drug Revenue Share by Players in 2020
Figure 44. Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Parkinson Disease Drug Revenue Market Share in 2020
Figure 46. Global Top 10 Players Parkinson Disease Drug Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Parkinson Disease Drug Revenue Share by Type in 2020
Figure 49. Global Parkinson Disease Drug Market Share Forecast by Type (2021-2026)
Figure 50. Global Parkinson Disease Drug Revenue Share by Application in 2020
Figure 51. Global Parkinson Disease Drug Market Share Forecast by Application (2021-2026)
Figure 52. North America Parkinson Disease Drug Sales Market Share by Type (2016-2026)
Figure 53. North America Parkinson Disease Drug Sales Market Share by Application (2016-2026)
Figure 54. North America Parkinson Disease Drug Revenue Market Share by Country (2016-2026)
Figure 55. United States Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Parkinson Disease Drug Sales Market Share by Type (2016-2026)
Figure 59. Europe Parkinson Disease Drug Sales Market Share by Application (2016-2026)
Figure 60. Europe Parkinson Disease Drug Revenue Market Share by Country (2016-2026)
Figure 61. Germany Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Parkinson Disease Drug Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Parkinson Disease Drug Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Region (2016-2026)
Figure 69. China Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Parkinson Disease Drug Sales Market Share by Type (2016-2026)
Figure 76. South America Parkinson Disease Drug Sales Market Share by Application (2016-2026)
Figure 77. South America Parkinson Disease Drug Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Parkinson Disease Drug Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Parkinson Disease Drug Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Parkinson Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
